Thank you, Mr. Chair.
Thanks to the witnesses for being here.
My first question would be to Ms. Haverstock with regard to my colleague Mr. Barlow's question. With 3-NOP and DSM—I didn't hear you correctly—did you say they applied or they haven't applied yet to Canada, or you're not sure at all?